Both in Pharmaceuticals
Pfizer vs Vertex Pharmaceuticals
Over the past year PFE returned +23.8% and VRTX returned +31.3%; their daily moves had a correlation of 0.43.
PFE +23.8% VRTX +31.3%Growth of $1, one year, split-adjusted
| Metric | PFE | VRTX |
|---|---|---|
| Price | $30.52 | $558.88 |
| Market cap | $173.95B | $141.65B |
| Today | +1.90% | +3.50% |
| 1 month | +8.5% | +10.3% |
| 6 months | +15.9% | +31.8% |
| Year to date | +22.6% | +23.3% |
| 1 year | +25.6% | +34.0% |
| Revenue growth (YoY) | +2.6% | +12.5% |
| Gross margin | 72.8% | 85.3% |
| Net margin | −1.6% | 33.0% |
| P/E (TTM) | 40.2× | 32.2× |
| Price / sales | 2.7× | 11.3× |
| Net cash | -$51.49B | $7.85B |
| Dividend yield | 5.64% | — |
| Volatility (60d) | 19.8% | 28.7% |
| Short % of float | 2.4% | 1.7% |
| Next earnings | Nov 3, 2026 | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).